CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...
As Delta Air Lines tries to woo passengers back to air travel, it has introduced new programs at two high-risk points at the airport.
Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the Delta and Omicron strains, though new mutation-specific antibody production dipped slightly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback